[Photo] For a World Without COVID-19
![[Photo] For a World Without COVID-19](http://www.asiae.co.kr/news/img_view.htm?img=2020122216110380237_1608621064.jpg)
Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus disease (COVID-19). The domestic bio venture company NGICAM Life Science is conducting Phase 2 clinical trials after receiving approval for a new drug substance from the U.S. Food and Drug Administration (FDA). Ahead of the New Year 2021, a researcher is studying the COVID-19 treatment EC-18 at NGICAM Life Science's central research institute in Jecheon, Chungbuk./Jecheon=Reporter Kang Jinhyung aymsdream@
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- 2030s Prefer Temples, 5060s Choose Art Museums... Data Reveals Diverging Travel Preferences
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
